Life Vantage Revenue and Competitors
Estimated Revenue & Valuation
- Life Vantage's estimated annual revenue is currently $149.2M per year.
- Life Vantage's estimated revenue per employee is $337,500
Employee Data
- Life Vantage has 442 Employees.
- Life Vantage grew their employee count by -2% last year.
Life Vantage's People
| Name | Title | Email/Phone |
|---|
Life Vantage Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $409M | 1082 | 15% | N/A | N/A |
#2 | $5.5M | 29 | -15% | N/A | N/A |
#3 | $31.3M | 116 | -13% | N/A | N/A |
#4 | $14.8M | 61 | -18% | N/A | N/A |
#5 | $13.1M | 54 | 8% | N/A | N/A |
#6 | $34.3M | 127 | 4% | N/A | N/A |
#7 | $219.4M | 650 | 17% | N/A | N/A |
#8 | $505.4M | 1337 | 22% | N/A | N/A |
#9 | $31.3M | 116 | 27% | N/A | N/A |
#10 | $123.2M | 365 | 13% | N/A | N/A |
What Is Life Vantage?
Direct Sales of the world's only Nrf2 activator supplement.
keywords:N/AN/A
Total Funding
442
Number of Employees
$149.2M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Life Vantage News
2022-04-13 - LifeVantage (NASDAQ:LFVN) Research Coverage Started at ...
LifeVantage (NASDAQ:LFVN) Research Coverage Started at StockNews.com. Posted by admin on Apr 20th, 2022. Share on Twitter Share on Facebook Share on...
2022-04-13 - LifeVantage to Announce Third Quarter Fiscal Year 2022 Results on May 3, 2022 - Benzinga
The Company's line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+...
2022-04-06 - StockNews.com Initiates Coverage on LifeVantage (NASDAQ:LFVN)
The brokerage set a buy rating on the stock. Shares of NASDAQ LFVN opened at $4.59 on Tuesday. LifeVantage has a 12 month low of $4.50 and a...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $160.2M | 442 | 5% | N/A |
#2 | $149.2M | 442 | N/A | N/A |
#3 | $138.7M | 442 | 5% | N/A |
#4 | $35M | 442 | N/A | N/A |
#5 | $149.2M | 442 | 0% | N/A |
